Updated August 26, 2026Expert Reviewed

Best Tirzepatide 5mg Providers in 2026 Ranked & Reviewed

Tirzepatide 5mg is the step-up dose tier. We compare every telehealth provider offering compounded tirzepatide or brand-name Mounjaro/Zepbound at this dose, ranked by price and independent score.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

1 tirzepatide providers compared · independently scored against our six-factor methodology.

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Methodology & sources

Providers in this variant are scored against our published six-factor rubric[1], then filtered to match the specific dose shown in the page title.

Published Phase 3 efficacy for tirzepatide (~20.9% mean weight loss at the 15 mg dose over 72 weeks) comes from the SURMOUNT-1 trial[2]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[3].

Quick Picks: Top 1

#ProviderScore
1Emerge Weight LossVisit

Detailed Reviews

1

Emerge Weight Loss

Best for: patients committed to tirzepatide as their drug of choice

7.7

Emerge Weight Loss is a nationwide telehealth platform focused specifically on compounded tirzepatide for medical weight management. Operates through licensed physicians via telemedicine consultations and ships nationwide. Tirzepatide-first positioning differentiates them from the broader semaglutide-heavy compounded market.

Score Breakdown

Value25%
7.5
Effectiveness25%
8
User Experience15%
7.5
Trust & Safety15%
7.3
Accessibility10%
8
Support10%
7.9

Frequently Asked Questions

Compounded tirzepatide 5mg typically ranges from $249–$549/month. Brand-name Mounjaro or Zepbound at this dose can run $1,000–$1,600/month without insurance.
Sources & methodology — as of August 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  3. 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.